|
1
|
Shete S, Lau CC, Houlston RS, et al:
Genome-wide high-density SNP linkage search for glioma
susceptibility loci: results from the Gliogene consortium. Cancer
Res. 71:7568–7575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sabo B: Primary malignant brain tumours,
psychosocial distress and the intimate partner experience: what do
we know? Can J Neurosci Nurs. 3:9–15. 2014.
|
|
3
|
Zhou LF: The first step in a
long-run-celebrating the announcement of ‘Guideline for the
management of CNS gliomas in China’. Zhonghua Yi Xue Za Zhi.
93:24172013.In Chinese.
|
|
4
|
Yang P, Wang Y, Peng X, et al: Management
and survival rates in patients with glioma in China (2004-2010): a
retrospective study from a single-institution. J Neurooncol.
113:259–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu JS, Zhang J, Zhuang DX, et al: Current
status of cerebral glioma surgery in China. Chin Med J (Engl).
124:2569–2577. 2011.
|
|
6
|
Wang J, Liu X, Ba YM, et al: Effect of
sonographically guided cerebral glioma surgery on survival time. J
Ultrasound Med. 31:757–762. 2012.PubMed/NCBI
|
|
7
|
Diaz-Miqueli A and Martinez GS:
Nimotuzumab as a radiosen-sitizing agent in the treatment of high
grade glioma: challenges and opportunities. Onco Targets Ther.
6:931–942. 2013. View Article : Google Scholar
|
|
8
|
Wu Z, Chan CL, Eastman A and Bresnick E:
Expression of human O6-methylguanine-DNA methyltransferase in
Chinese hamster ovary cells and restoration of cellular resistance
to certain N-nitroso compounds. Mol Carcinog. 4:482–488. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Liu L, Liu X, et al: Shugoshin1
enhances multidrug resistance of gastric cancer cells by regulating
MRP1, Bcl-2 and Bax genes. Tumour Biol. 34:2205–2214. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheung KK, Chan JY and Fung KP:
Antiproliferative effect of pheophorbide a-mediated photodynamic
therapy and its synergistic effect with doxorubicin on multiple
drug-resistant uterine sarcoma cell MES-SA/Dx5. Drug Chem Toxicol.
36:474–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ching J, Amiridis S, Stylli SS, et al: A
novel treatment strategy for glioblastoma multiforme and glioma
associated seizures: increasing glutamate uptake with PPARγ
agonists. J Clin Neurosci. 1:21–28. 2015. View Article : Google Scholar
|
|
12
|
Abbott BD: Review of the expression of
peroxisome prolif-erator-activated receptors alpha (PPAR alpha),
beta (PPAR beta) and gamma (PPAR gamma) in rodent and human
development. Reprod Toxicol. 27:246–257. 2009. View Article : Google Scholar
|
|
13
|
Khoo NK, Hebbar S, Zhao W, et al:
Differential activation of catalase expression and activity by PPAR
agonists: implications for astrocyte protection in anti-glioma
therapy. Redox Biol. 1:70–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai Y, Liao H, Liu T, et al: MiR-296-3p
regulates cell growth and multi-drug resistance of human
glioblastoma by targeting ether-à-go-go (EAG1). Eur J Cancer.
49:710–724. 2013. View Article : Google Scholar
|
|
15
|
Reka AK, Goswami MT, Krishnapuram R, et
al: Molecular cross-regulation between PPAR-γ and other signaling
pathways: implications for lung cancer therapy. Lung Cancer.
72:154–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawai M and Rosen CJ: PPARγ: a circadian
transcription factor in adipogenesis and osteogenesis. Nat Rev
Endocrinol. 6:629–636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Siersbaek R, Nielsen R and Mandrup S:
PPARgamma in adipocyte differentiation and metabolism-novel
insights from genome-wide studies. FEBS Lett. 584:3242–3249. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martín V, Sanchez-Sanchez AM, Herrera F,
et al: Melatonin-induced methylation of the ABCG2/BCRP promoter as
a novel mechanism to overcome multidrug resistance in brain tumour
stem cells. Br J Cancer. 108:2005–2012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Quezada C, Peigñan L, Segura R, et al:
Study of resistance to chemotherapy mediated by ABC transporters in
biopsies of glioblastoma multiforme. Rev Med Chil. 139:415–424.
2011.In Spanish. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garrido W, Muñoz M, San Martín R and
Quezada C: FK506 confers chemosensitivity to anticancer drugs in
glioblastoma multiforme cells by decreasing the expression of the
multiple resistance-associated protein-1. Biochem Biophys Res
Commun. 411:62–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shityakov S and Förster C: Multidrug
resistance protein P-gp interaction with nanoparticles (fullerenes
and carbon nanotube) to assess their drug delivery potential: a
theoretical molecular docking study. Int J Comput Biol Drug Des.
6:343–357. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu FS, Chen XM, Huang ZG, et al:
Rofecoxib augments anticancer effects by reversing intrinsic
multidrug resistance gene expression in BGC-823 gastric cancer
cells. J Dig Dis. 11:34–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou YT, Li K and Tian H: Effects of
vinorelbine on cisplatin resistance reversal in human lung cancer
A549/DDP cells. Asian Pac J Cancer Prev. 14:4635–4639. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryan BM, O’Donovan N and Duffy MJ:
Survivin: a new target for anti-cancer therapy. Cancer Treat Rev.
35:553–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Horowitz JC, Ajayi IO, Kulasekaran P, et
al: Survivin expression induced by endothelin-1 promotes
myofibroblast resistance to apoptosis. Int J Biochem Cell Biol.
44:158–169. 2012. View Article : Google Scholar
|
|
26
|
Zhu Y, Liu XJ, Yang P, et al:
Alkylglyceronephosphate synthase (AGPS) alters the lipids signaling
pathways and support the chemotherapy resistance of glioma and
hepatic carcinoma cell lines. Asian Pac J Cancer Prev.
15:3219–3226. 2014. View Article : Google Scholar
|
|
27
|
Bharatham N, Chi SW and Yoon HS: Molecular
basis of Bcl-X(L)-p53 interaction: insights from molecular dynamics
simulations. PLoS One. 6:e260142011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zandbergen F, Mandard S, Escher P, et al:
The G0/G1 switch gene 2 is a novel PPAR target gene. 392:313–324.
2005.
|
|
29
|
Yuan L, Zhang Y, Xia J, et al: Resveratrol
induces cell cycle arrest via a p53-independent pathway in A549
cells. Mol Med Rep. 4:2459–2464. 2015.
|
|
30
|
Liu LC, Tsao TC, Hsu SR, et al: EGCG
inhibits transforming growth factor-β-mediated
epithelial-to-mesenchymal transition via the inhibition of Smad2
and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. J
Agric Food Chem. 60:9863–9873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gilmore TD: Introduction to NF-kappaB:
players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakamura T, Toita H, Yoshimoto A, et al:
Potential involvement of Twist2 and Erk in the regulation of
osteoblastogenesis by HB-EGF-EGFR signaling. Cell Struct Funct.
35:53–61. 2010. View Article : Google Scholar : PubMed/NCBI
|
